Menu
Inhale the relief, exhale the grief.
Free initial consultation, intake, history and physical.
$3,600 for a course of 8 treatment sessions.
$4,200 for a course of 4 treatment sessions with ketamine assisted therapy.
$450 for each additional booster session after a standard course.
$150 for each additional ketamine assisted therapy session.
5-10 minutes
25-45%
40 minutes
30-60 minutes
90-120 minutes.
Varies from person to person based on body weight, medical and medication history.
Intranasal ketamine is administered by spraying the medication into the nostrils. This route is ideal for patients who prefer not to receive their treatments intravenously (IV). Despite the safety and efficacy of ketamine, each therapeutic treatment session requires the direct supervision of one of AVYIA’s healthcare providers but can be taken from the comfort of your own home. You get the same benefits and results of IV ketamine, just minus the needle poke.
Intranasal ketamine is administered twice a week for 4 weeks, amounting to a total of 8 treatment sessions for optimal results. Most patients report drastic improvements in their mood starting with the first or second treatment. Some achieve complete remission of their disorders, while others may need booster sessions until remission is attained.
For enhanced results, the optional addition of ketamine-assisted psychotherapy can be incorporated into your intranasal sessions. Ketamine-assisted psychotherapy is a guided treatment overseen by a licensed therapist.
Ketamine is a member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group. Ketamine was originally developed as an anesthetic, but has gained interest in recent years for its success in treating various mental health disorders. Research is ongoing, but here's what we know about ketamine's effects and abilities to treat mental health disorders:
One of the most prominent features of ketamine when used to treat depression, especially treatment-resistant depression, is its ability to produce rapid antidepressant effects, often within hours to a few days.
Ketamine is an antagonist of the N-methyl-D-aspartate (NMDA) receptor, a type of glutamate receptor. This action is believed to play a role in its antidepressant effects, though the precise mechanisms are still under study.
Ketamine is believed to enhance synaptic plasticity, the ability of synapses to strengthen or weaken over time. This enhancement can promote the formation of new neural connections, which can be beneficial for mental health.
Ketamine has been shown to increase the release of brain-derived neurotrophic factor (BDNF), a protein that supports the survival of existing neurons and encourages the growth and differentiation of new neurons and synapses.
Some research suggests that ketamine may temporarily reduce the connectivity between certain parts of the brain, which might help "reset" dysfunctional brain networks seen in depression.
There's emerging evidence that inflammation might play a role in mood disorders. Ketamine has shown potential anti-inflammatory effects that could contribute to its therapeutic benefits.
Ketamine has demonstrated a rapid reduction in suicidal ideation in some individuals, which is of particular interest for emergency psychiatric interventions.
Preliminary research suggests that, in addition to depression, ketamine may be beneficial in treating post-traumatic stress disorder (PTSD) and some anxiety disorders.
There's some evidence to suggest that ketamine may have neuroprotective effects, helping to protect the brain from stress-induced damage and reduce brain injury (TBI) and Ischemia.
Some studies have explored the use of ketamine for its rapid antidepressant effects in treating bipolar disorder and other mood disorders. Ketamine plays a role in offering mood-stabilizing benefits to mental health patients.
